Dorothy Hodgkin lecture 2023: The enteroendocrine system—Sensors in your guts

F Reimann - Diabetic Medicine, 2023 - Wiley Online Library
Abstract Glucagon‐like peptide‐1 (GLP‐1)‐based medication is now widely employed in the
treatment of type 2 diabetes and obesity. Like other gut hormones, GLP‐1 is released from …

Phage display technology and its impact in the discovery of novel protein-based drugs

CJ Hutchings, AK Sato - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction Phage display technology is a well-established versatile in vitro display
technology that has been used for over 35 years to identify peptides and antibodies for use …

[HTML][HTML] Dysregulation of Metabolic Peptides in the Gut–Brain Axis Promotes Hyperinsulinemia, Obesity, and Neurodegeneration

C Green, V Zaman, K Blumenstock, NL Banik, A Haque - Biomedicines, 2025 - mdpi.com
Metabolic peptides can influence metabolic processes and contribute to both inflammatory
and/or anti-inflammatory responses. Studies have shown that there are thousands of …

[PDF][PDF] Hyperinsulinemic Hypoglycemia in Childhood.

MN Özbek, Ö Orhan - European Journal of Therapeutics, 2023 - pdfs.semanticscholar.org
Hyperinsulinemic Hypoglycemia (HH) is the most common cause of permanent
hypoglycemia, especially in the neonatal period. Childhood HH is mostly related to genes …

Hyperinsulinemic Hypoglycemia in Childhood

MN Özbek, Ö Orhan - European Journal of Therapeutics, 2023 - eurjther.com
Hyperinsulinemic Hypoglycemia (HH) is the most common cause of permanent
hypoglycemia, especially in the neonatal period. Childhood HH is mostly related to genes …

METHODS AND COMPOSITIONS RELATED TO GLP1R VARIANTS

A Sato, P Garg, Q Liu, F Axelrod - 2024 - Google Patents
EP4204460A4 - METHODS AND COMPOSITIONS RELATED TO GLP1R VARIANTS -
Google Patents EP4204460A4 - METHODS AND COMPOSITIONS RELATED TO GLP1R …